Scinai Immunotherapeutics Ltd. (TLV:BVXV)
49.30
-1.00 (-1.99%)
At close: Jan 18, 2018
Scinai Immunotherapeutics Employees
Scinai Immunotherapeutics had 45 employees as of December 31, 2025. The number of employees increased by 14 or 45.16% compared to the previous year.
Employees
45
Change (1Y)
14
Growth (1Y)
45.16%
Revenue / Employee
92.88K ILS
Profits / Employee
-588.50K ILS
Market Cap
5.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | 14 | 45.16% |
| Dec 31, 2024 | 31 | 0 | - |
| Dec 31, 2023 | 31 | -2 | -6.06% |
| Dec 31, 2022 | 33 | 18 | 120.00% |
| Dec 31, 2021 | 15 | -6 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Imed Infinity Medical-Limited Partnership | 80 |
| Menara Ventures Xl - Limited Partnership | 11 |
| Sonovia | 11 |
| Storage Drop Storage Technologies | 9 |
| Rotem Energy Mineral (REM) - Limited Partnership | 4 |
Scinai Immunotherapeutics News
- 4 days ago - Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility - PRNewsWire
- 9 days ago - Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe - PRNewsWire
- 4 weeks ago - Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today? - TipRanks
- 4 weeks ago - Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today - Benzinga
- 4 weeks ago - Scinai Immunotherapeutics announces $2.61M private placement - TheFly
- 4 weeks ago - Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing - PRNewsWire
- 6 weeks ago - Scinai Immunotherapeutics completes strategic reorganization - TheFly
- 6 weeks ago - Scinai Immunotherapeutics targets $5M in CDMO revenue in 2026 - TheFly